<p>The present invention is directed to therapeutic agents of the formula (I) which are atypical antipsychotics and which are useful in the treatment of neurological and psychiatric disorders associated with dopamine D2 and serotonin 5-HT2A neurotransmission dysfunction. wherein; R1 is C1-6alkyl, which is unsubstituted or substituted with 1-6 fluoro, wherein R1 and the hydroxyl group on the ring are attached to the same carbon atom; or a pharmaceutically acceptable salt thereof.</p>
申请公布号
MY153868(A)
申请公布日期
2015.03.30
申请号
MY2009PI04078
申请日期
2008.04.03
申请人
MERCK SHARP & DOHME CORP.
发明人
BILODEAU, MARK T.;NANDA, KAUSIK, K.;TROTTER, B. WESLEY